Open Government Portal
Letter from the Agency president outlining the IAC priorities for 2022-23.
This Notice sets out the policies and practices pertaining to the administration of Sugar.
Health Canada reviewed the potential risk of impotence (erectile dysfunction) with the use of oral retinoids because of a publication …
A Health Canada safety review was carried out as a follow-up assessment on the potential risk of retinal detachment with …
In 2014, Health Canada completed a first safety review for the Omnipod because a high number of complaints, reporting high …
After becoming aware of international reports about neurological side effects, such as anxiety, panic reaction, visual hallucinations and seizures, possibly …
Health Canada carried out a safety review to investigate the potential risk of developing an abnormal heart rhythm (QT interval …
Health Canada carried out a safety review after learning that the European Medicines Agency was looking into a potential interaction …
Health Canada completed a safety review to evaluate if using digoxin was linked to a higher risk of death compared …
Health Canada reviewed the potential risk of acute kidney injury with the use of levetiracetam, because of an article that …